PLATINUM INVESTMENT MANAGEMENT LTD - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
PLATINUM INVESTMENT MANAGEMENT LTD ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$3,119,000
+6.7%
56,5930.0%0.07%
+10.8%
Q1 2021$2,922,000
-1.9%
56,593
-17.7%
0.06%
-4.4%
Q4 2020$2,979,000
+23.8%
68,7520.0%0.07%
+13.3%
Q3 2020$2,406,000
-34.6%
68,7520.0%0.06%
-28.6%
Q2 2020$3,677,000
+50.8%
68,7520.0%0.08%
+35.5%
Q1 2020$2,439,000
-16.8%
68,752
+11.9%
0.06%
+6.9%
Q4 2019$2,933,000
+77.2%
61,434
+20.3%
0.06%
+56.8%
Q3 2019$1,655,000
-11.4%
51,083
+36.5%
0.04%
-15.9%
Q2 2019$1,867,000
-26.1%
37,4360.0%0.04%
-25.4%
Q1 2019$2,525,000
+46.3%
37,4360.0%0.06%
+1.7%
Q4 2018$1,726,000
-25.9%
37,436
+24.0%
0.06%
-12.1%
Q3 2018$2,329,000
-8.5%
30,2000.0%0.07%
+10.0%
Q2 2018$2,544,000
+3.0%
30,2000.0%0.06%
-13.0%
Q1 2018$2,469,000
+20.7%
30,200
-15.6%
0.07%
+27.8%
Q4 2017$2,046,000
-14.4%
35,8000.0%0.05%
-10.0%
Q3 2017$2,389,000
+29.8%
35,8000.0%0.06%
+20.0%
Q2 2017$1,841,000
-11.9%
35,8000.0%0.05%
-13.8%
Q1 2017$2,090,000
+40.0%
35,8000.0%0.06%
+31.8%
Q4 2016$1,493,000
-32.0%
35,800
-13.9%
0.04%
-13.7%
Q3 2016$2,197,00041,6000.05%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders